pmid	doi	year	title	Hugo_Symbol
30155344	10.1186/s40164-018-0112-y	2022	The association of HLA-C alleles with multiple myeloma in Chinese patients.	HLA-C
35114151	10.1016/S2352-3026(21)00369-0	2022	KIR2DS1-HLA-C status as a predictive marker for benefit from rituximab: a post-hoc analysis of the RICOVER-60 and CLL8 trials.	HLA-C
35358442	10.1016/S2352-3026(22)00036-9	2022	In-vivo T-cell depleted reduced-intensity conditioned allogeneic haematopoietic stem-cell transplantation for patients with acute lymphoblastic leukaemia in first remission: results from the prospective, single-arm evaluation of the UKALL14 trial.	HLA-C
31428523	10.1080/2162402X.2019.1625688	2021	NPM-ALK-reactive T-cell responses in children and adolescents with NPM-ALK positive anaplastic large cell lymphoma.	HLA-C
31704471	10.1016/j.bbmt.2019.10.032	2021	Increased Relapse Risk of Acute Lymphoid Leukemia in Homozygous HLA-C1 Patients after HLA-Matched Allogeneic Transplantation: A Japanese National Registry Study.	HLA-C
32883310	10.1186/s12977-020-00536-y	2021	HLA-B*35 as a new marker for susceptibility to human T-cell lymphotropic virus type 1 (HTLV-1) Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) in patients living in Argentina.	HLA-C
33622167	10.1080/10428194.2021.1885655	2021	Specific HLA alleles, paired with TCR V- and J-gene segment usage, link to distinct multiple myeloma survival rates.	HLA-C
30715139	10.1093/asj/sjz021	2020	Differences in Human Leukocyte Antigen Expression Between Breast Implant-Associated Anaplastic Large Cell Lymphoma Patients and the General Population.	HLA-C
30871628	10.1186/s40425-019-0538-8	2020	Follicular lymphoma patients with KIR2DL2 and KIR3DL1 and their ligands (HLA-C1 and HLA-Bw4) show improved outcome when receiving rituximab.	HLA-C
31958417	10.1016/S2352-3026(19)30220-0	2020	Addition of anti-thymocyte globulin to standard graft-versus-host disease prophylaxis versus standard treatment alone in patients with haematological malignancies undergoing transplantation from unrelated donors: final analysis of a randomised, open-label, multicentre, phase 3 trial.	HLA-C
29197675	10.1016/j.bbmt.2017.11.029	2019	Homozygous HLA-C1 is Associated with Reduced Risk of Relapse after HLA-Matched Transplantation in Patients with Myeloid Leukemia.	HLA-C
30001986	10.1016/j.clml.2018.06.011	2019	A Pilot Trial of Lirilumab With or Without Azacitidine for Patients With Myelodysplastic Syndrome.	HLA-C
26527563	10.1111/bjh.13777	2018	Selective downregulation of HLA-C and HLA-E in childhood acute lymphoblastic leukaemia.	HLA-C
27090957	10.1016/j.bbmt.2016.04.007	2018	Killer Cell Immunoglobulin-Like Receptor-Ligand Matching and Outcomes after Unrelated Cord Blood Transplantation in Acute Myeloid Leukemia.	HLA-C
27273744	10.1111/tan.12829	2018	The effect of missing KIR ligands, activating KIR genotype and haplotype on the outcome of T-cell-replete hematopoietic stem cell transplantation from HLA-identical siblings in Thai patients.	HLA-C
28722359	10.1111/tan.13087	2018	A novel allele, HLA-C*14:02:01:03, identified by full-length genomic sequencing.	HLA-C
27414060	10.1111/cei.12842	2017	Analysis of nucleophosmin-anaplastic lymphoma kinase (NPM-ALK)-reactive CD8(+) T cell responses in children with NPM-ALK(+) anaplastic large cell lymphoma.	HLA-C
26472014	10.1016/j.humimm.2015.10.009	2016	Genetic associations of killer immunoglobulin like receptors and class I human leukocyte antigens on childhood acute lymphoblastic leukemia among north Indians.	HLA-C
24533560	10.1111/jdv.12391	2015	Immunogenetic factors in mycosis fungoides: can the HLA system influence the susceptibility and prognosis of the disease? Long-term follow-up study of 46 patients.	HLA-C
25515183	10.1111/tan.12485	2015	The full length genomic sequence of a novel HLA-C*03 allele: HLA-C*03:219.	HLA-C
25627829	10.1007/s10875-014-0125-1	2015	Combined immunodeficiency due to MALT1 mutations, treated by hematopoietic cell transplantation.	HLA-C
25802187	10.1002/hep.27794	2015	Genetic variants in five novel loci including CFB and CD40 predispose to chronic hepatitis B.	HLA-C
24131084	10.1111/tan.12208	2014	Novel HLA-C*07:314 allele identified by sequence-based typing in a French lymphoblastic leukemia patient.	HLA-C
25163702	10.1182/blood-2014-05-572065	2014	KIR ligand C2 is associated with increased susceptibility to childhood ALL and confers an elevated risk for late relapse.	HLA-C
22676066	10.3109/08820139.2012.691148	2013	HLA-C matching status does not affect rituximab-mediated antibody-dependent cellular cytotoxicity by allogeneic natural killer Cells.	HLA-C
22923051	10.1007/s00251-012-0648-7	2013	The impact of HLA-C matching depends on the C1/C2 KIR ligand status in unrelated hematopoietic stem cell transplantation.	HLA-C
23843497	10.1182/blood-2013-02-483420	2013	HLA specificities are related to development and prognosis of diffuse large B-cell lymphoma.	HLA-C
24043749	10.1200/JCO.2012.47.4007	2013	Effect of donor KIR2DL1 allelic polymorphism on the outcome of pediatric allogeneic hematopoietic stem-cell transplantation.	HLA-C
21982422	10.1016/S1470-2045(11)70260-1	2012	Effect of donor-recipient HLA matching at HLA A, B, C, and DRB1 on outcomes after umbilical-cord blood transplantation for leukaemia and myelodysplastic syndrome: a retrospective analysis.	HLA-C
22035606	10.1111/j.1399-0039.2011.01778.x	2012	Characterization of the novel HLA-C*16:07:02 allele in a family of Benin origin.	HLA-C
22340965	10.1016/S1470-2045(12)70004-9	2012	Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study.	HLA-C
20870028	10.1016/j.bbmt.2010.09.012	2011	HLA-C antigen mismatch is associated with worse outcome in unrelated donor peripheral blood stem cell transplantation.	HLA-C
21059899	10.1182/blood-2010-08-301598	2011	MHC variation and risk of childhood B-cell precursor acute lymphoblastic leukemia.	HLA-C
21067287	10.3109/08916930903567492	2011	Multiple sclerosis risk markers in HLA-DRA, HLA-C, and IFNG genes are associated with sex-specific childhood leukemia risk.	HLA-C
21299541	10.1111/j.1399-0039.2010.01610.x	2011	HLA-C*03:93, a novel HLA-C*03 allele identified by sequence-based typing.	HLA-C
20056126	10.1016/j.exphem.2009.12.007	2010	B-lymphoma cells escape rituximab-triggered elimination by NK cells through increased HLA class I expression.	HLA-C
20196822	10.1111/j.1399-0039.2009.01398.x	2010	Identification of the novel allele Cw*040110 in a German patient.	HLA-C
20385791	10.1182/blood-2010-01-266775	2010	Human leukocyte antigen class I and II alleles in non-Hodgkin lymphoma etiology.	HLA-C
20558104	10.1016/S1470-2045(10)70127-3	2010	Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis.	HLA-C
18544086	10.1111/j.1365-2141.2008.07177.x	2009	Impact of HLA-DPB1 allelic and single amino acid mismatches on HSCT.	HLA-C
18841361	10.1007/s00262-008-0601-7	2009	Role of the inhibitory KIR ligand HLA-Bw4 and HLA-C expression levels in the recognition of leukemic cells by Natural Killer cells.	HLA-C
19363276		2009	Posttransplant malignancies and their relationship with human leukocyte antigens in kidney allograft recipients.	HLA-C
19493232	10.1111/j.1399-0039.2009.01235.x	2009	Killer immunoglobulin-like receptors (KIR2DL2 and/or KIR2DS2) in presence of their ligand (HLA-C1 group) protect against chronic myeloid leukaemia.	HLA-C
19620980	10.1038/ng.419	2009	Genetic variants at 6p21.33 are associated with susceptibility to follicular lymphoma.	HLA-C
17971052	10.1111/j.1399-0039.2007.00954.x	2008	Haplotype-specific pattern of association of human major histocompatibility complex with non-Hodgkin's lymphoma outcome.	HLA-C
18005680	10.1016/j.chom.2007.01.001	2008	A two-pronged mechanism for HIV-1 Nef-mediated endocytosis of immune costimulatory molecules CD80 and CD86.	HLA-C
18301962	10.1007/s12185-008-0040-4	2008	Association of HLA alleles with non-Hodgkin's lymphoma in Korean population.	HLA-C
17145860	10.1158/0008-5472.CAN-06-2326	2007	Isolation of germ cells from leukemia and lymphoma cells in a human in vitro model: potential clinical application for restoring human fertility after anticancer therapy.	HLA-C
17302780	10.1111/j.1537-2995.2007.01109.x	2007	A possible role for the production of multiple HLA antibodies in fatal platelet transfusion refractoriness after peripheral blood progenitor cell transplantation from the mother in a patient with relapsed leukemia.	HLA-C
17311253	10.1002/gcc.20436	2007	Association of human leukocyte antigen ancestral haplotype 8.1 with adverse outcome of non-Hodgkin's lymphoma.	HLA-C
17560447	10.1016/S0140-6736(07)60915-5	2007	Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study.	HLA-C
17909631	10.1172/JCI32377	2007	HLA class I polymorphisms are associated with development of infectious mononucleosis upon primary EBV infection.	HLA-C
15731175	10.1182/blood-2004-12-4825	2005	Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes.	HLA-C
14727382		2004	[Association of HLA class I and leukemia in mestizo patients of the state of Zulia, Venezuela].	HLA-C
12688350	10.1080/1042819021000035707	2003	Association of familial leukemia with HLA Cw3: is it real?	HLA-C
14515258	10.1002/eji.200324182	2003	Differential effects of US2, US6 and US11 human cytomegalovirus proteins on HLA class Ia and HLA-E expression: impact on target susceptibility to NK cell subsets.	HLA-C
12010826	10.1182/blood.v99.11.4200	2002	The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors.	HLA-C
12060128	10.1046/j.1365-2141.2002.03504.x	2002	Human leucocyte antigen-Cw-specific cytotoxic T lymphocytes generated from naive cord blood used for cord blood stem cell transplantation.	HLA-C
12148880	10.1080/10428190290021588	2002	Increased frequency of homozygosity for HLA class II loci in female patients with chronic lymphocytic leukemia.	HLA-C
10715516	10.1016/s0198-8859(99)00186-x	2000	Differential expression of human major histocompatibility class I loci: HLA-A, -B, and -C.	HLA-C
10717799	10.1016/s0198-8859(99)00147-0	2000	Unrelated donors selected prospectively by block-matching have superior bone marrow transplant outcome.	HLA-C
10498594		1999	Children with acute lymphoblastic leukemia who receive T-cell-depleted HLA mismatched marrow allografts from unrelated donors have an increased incidence of primary graft failure but a similar overall transplant outcome.	HLA-C
9753057	10.1046/j.1365-2141.1998.00919.x	1998	Lack of association between childhood common acute lymphoblastic leukaemia and an HLA-C locus dimorphism influencing the specificity of natural killer cells.	HLA-C
9780337	10.1056/NEJM199810223391701	1998	Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. Japan Marrow Donor Program.	HLA-C
7761977	10.1111/j.1399-0039.1995.tb02437.x	1995	The HLA-A,B,C genotype of the class I negative cell line Daudi reveals novel HLA-A and -B alleles.	HLA-C
1326579		1992	Cytotoxic T lymphocytes show HLA-C-restricted recognition of EBV-bearing cells and allorecognition of HLA class I molecules presenting self-peptides.	HLA-C
1655115		1991	Cell phenotype dependent expression of MHC class I antigens in Burkitt's lymphoma cell lines.	HLA-C
1899854	10.1002/ijc.2910470412	1991	Aberrant expression of HLA class-I antigens in Burkitt lymphoma cells.	HLA-C
2395381		1990	Immunophenotypic and HLA studies in childhood acute lymphoblastic leukemia in Trinidad, West Indies.	HLA-C
2804917	10.1002/1097-0142(19891201)64:11&lt;2259::aid-cncr2820641113&gt;3.0.co;2-0	1989	Possible disorder of B-cell-related surveillance and malignant lymphoma of the thyroid.	HLA-C
3209056	10.1002/gepi.1370050609	1989	Significant association of acute lymphoblastic leukemia with HLA-Cw7.	HLA-C
2450918		1988	Specific associations of fluorescent beta-2-microglobulin with cell surfaces. The affinity of different H-2 and HLA antigens for beta-2-microglobulin.	HLA-C
3131426		1988	Isolation and nucleotide sequence of a cDNA clone encoding a novel HLA class I gene.	HLA-C
3164632	10.1111/j.1365-2141.1988.tb07626.x	1988	More familial leukaemia in ALL patients with both unexplained high transcortin levels and an HLA antigen Cw3.	HLA-C
2423453	10.3109/08820138609042018	1986	Study on the association of HLA with malignant lymphoma.	HLA-C
2578520		1985	Delineation of three subsets of class I human T antigens (HTA) on Molt-4 cells: serologic and regulatory relationship to HLA class I antigens.	HLA-C
3872893	10.1016/s0190-9622(85)70075-8	1985	Human leukocyte antigens in cutaneous T cell lymphoma.	HLA-C
6303316	10.1042/bj2100079	1983	Human class I histocompatibility antigens (HLA-A,B,C). A small proportion only is phosphorylated.	HLA-C
6960462		1983	[Detection of HLA-A, B and C antigens on various normal and pathologic cells using the monoclonal antibody W6/32].	HLA-C
6181407		1982	Lack of expression of HLA-ABC antigens in choriocarcinoma and other human tumor cell lines.	HLA-C
6951167	10.1073/pnas.79.4.1190	1982	Introduction of a human X-6 translocation chromosome into a mouse teratocarcinoma: investigation of control of HLA-A, B, C expression.	HLA-C
